Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04823273 · ClinicalTrials.gov registry record · NA
Blood Transfusion Reduction - QI Project
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 1,640
- Enrollment target
NCT04823273 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 1,640 participants.
The verdict
NCT04823273, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,640 participants
- Enrollment target
Study Summary
Blood Banks of large medical centers have large annual budgets, typically millions of dollars. Blood product wastage results in not only in a loss of the product's cost, but also of the fees involved in transporting, handling, and administering these products. Optimal utilization of blood products requires a balance between maximizing patient clinical outcomes while avoiding unnecessary costs and risks associated with transfusions. This project will specifically focus on packed red blood cell transfusions (pRBCs). There are clear guidelines for transfusing pRBCs however these guidelines are not always followed. pRBC transfusions outside of recommended guidelines is associated with increased risk of harm to patients. Our aim is to improve adherence to guideline indicated pRBC transfusions for patient in the UCHealth system thereby decreasing inappropriate (non-guideline indicated) pRBC transfusions. We will conduct a QI project seeking to improve pRBC transfusion guideline adherence. This project will involve data review to establish baseline rates, multimodal interventions to improve adherence to pRBC transfusion guidelines including provider education, modifications to the electronic ordering interface, and changing blood back policies at participating institutions.
Interventions
- BEHAVIORAL General improvement
- BEHAVIORAL In-line help text
- BEHAVIORAL Interruptive alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,640 participants |
| Start Date | 2021-04-06 |
| Est. Completion | 2022-10-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04823273
The ClinicalTrials.gov registry entry for NCT04823273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,640 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which General improvement is the first listed.
NCT04823273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04823273 about?
NCT04823273 is a clinical study titled "Blood Transfusion Reduction - QI Project". Blood Banks of large medical centers have large annual budgets, typically millions of dollars. Blood product wastage results in not only in a loss of the product's cost, but also of the fees involved in transporting, handling, and administering these products. Optimal utilization of blood products r...
What is the current status of trial NCT04823273?
This trial is currently completed. It is a NA study. The enrollment target is 1,640 participants. The study started on 2021-04-06. Estimated completion is 2022-10-15.
What interventions are being tested in trial NCT04823273?
The interventions under investigation include: General improvement (BEHAVIORAL), In-line help text (BEHAVIORAL), Interruptive alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT04823273?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.